By Unknown Author
Insurers are hoping that a new competitor to Gilead Sciences’ drugs for the disease will drive down prices.
Published: December 20, 2014 at 12:00AM
from NYT Business Day http://ift.tt/1CeuIY6
from WordPress http://ift.tt/1wuTXVL
via Hadi Aboukhater
No comments:
Post a Comment